The dynamic Russian pharmaceutical industry confronts a web of legal obstacles that significantly impact investment strategies and the introduction of new medications. Central concerns revolve around interdepartmental coordination in enforcing court and the Federal Antimonopoly Service rulings, challenges in obtaining interim measures, and the absence of clear criteria for granting compulsory licenses through judicial processes.
These pressing issues formed the backbone of a robust discussion at the inaugural joint conference of the Association of International Pharmaceutical Manufacturers (AIPM) and ALUMNI Partners, titled "AIPM and ALUMNI Partners Patent Conference: Strategies and Legal Protection." Held on October 21, 2025, in Moscow, the event was supported by Vademecum.
Attendees, numbering over 80, included leading experts in intellectual property and representatives from key regulatory bodies such as the Ministry of Economic Development of Russia, the Federal Antimonopoly Service, the Eurasian Patent Office, and the Federal Institute for Industrial Property of Rospatent. The dialogue centered on current methods of safeguarding intellectual property rights and potential avenues for enhancing regulatory and enforcement practices.
These pressing issues formed the backbone of a robust discussion at the inaugural joint conference of the Association of International Pharmaceutical Manufacturers (AIPM) and ALUMNI Partners, titled "AIPM and ALUMNI Partners Patent Conference: Strategies and Legal Protection." Held on October 21, 2025, in Moscow, the event was supported by Vademecum.
Attendees, numbering over 80, included leading experts in intellectual property and representatives from key regulatory bodies such as the Ministry of Economic Development of Russia, the Federal Antimonopoly Service, the Eurasian Patent Office, and the Federal Institute for Industrial Property of Rospatent. The dialogue centered on current methods of safeguarding intellectual property rights and potential avenues for enhancing regulatory and enforcement practices.